CNS Neuroscience & Therapeutics
(Redirected from CNS Drug Rev.)
| Discipline | Neurology |
|---|---|
| Language | English |
| Edited by | Mark H. Pollack, Roger Bullock |
| Publication details | |
Former name(s) | CNS Drug Reviews |
| History | 1995–present |
| Publisher | |
| Frequency | Bimonthly |
| 7.035 (2021) | |
| Standard abbreviations | |
| ISO 4 | CNS Neurosci. Ther. |
| Indexing | |
| ISSN | 1755-5930 (print) 1755-5949 (web) |
| LCCN | 2008243471 |
| OCLC no. | 221972947 |
| Links | |
CNS Neuroscience & Therapeutics is a bimonthly peer-reviewed medical journal established in 1995 as CNS Drug Reviews and obtained its current title in 2008. It is published by Wiley-Blackwell and addresses topics in neurology and central nervous system therapeutic pharmacology.
External links
[edit]
  | This article about a pharmacology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
 | This article about a neurology journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |